Skip to main content
Equibles

BETA · Beta Drugs Limited · Documents

Use BETA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BETA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,817.40 INR -21.10 (-1.15%) At close · Nov 13
Rebalance outlook locked
Market Cap
20.21B INR
Shares
11.12M
Volume · Nov 13 11.61K Avg daily vol (3M) 40.37K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Oct 22, 2026
2026
Oct 22
Earnings call
Q2 2027 earnings call

Beta Drugs reported H1 FY27 revenue growth of 29.2%, EBITDA margin of 23.18% and PAT growth of almost 45% to INR34 crores. Management targets 20%, 25% growth, FY27 own-brand sales of INR150 crores and said trade margin capping has negligible impact.

Showing 1–2 of 2 documents